The door to a new era has been opened in the fight against the COVID-19 epidemic, which has been in our lives for almost 2 years. The world’s first oral antiviral coronavirus pill Molnupiravir An emergency use authorization has been requested from the US Food and Drug Administration (FDA). The pill, developed by the US-based pharmaceutical company Merck, will be ‘the first oral antiviral drug used in the treatment of COVID-19’, if authorized.
Right now new coronavirus (SARS-CoV-2) The only way to fight the disease: developed vaccines. Produced by BioNTech & Pfizer Comirnaty The COVID-19 vaccine, named COVID-19, received full-use approval from the FDA in August. Other vaccines currently authorized for emergency use are not yet available. ‘full approval’ did not reach the stage.
The astonishing price of the world’s first COVID-19 pill has been revealed!
Molnupiravir, the first drug developed against the COVID-19 epidemic, has completed its clinical studies. Here are the first works…
Molnupiravir halves death and hospitalization rate
Merck and Ridgeback Biotherapeutics As a result of the Phase-3 clinical trials of the Molnupiravir pill developed in partnership with the company, the risk of death and hospitalization of those with mild to moderate COVID-19 cut in half announced. In line with the positive results obtained, it was stated that an emergency use authorization was requested from the FDA in order to make the drug available to the citizens.
In addition to the US Food and Drug Administration, Merck announced that it has started to work on obtaining authorization from other authorities around the world. According to the information in the press release, by the end of 2021 if the company manages to get the authorization. 10 million Molnupiravir pills will produce. In 2022, it will make more pills available.
The price of a single dose of molnupiravir was controversial
While the whole world turned their eyes to the positive or negative decision from the FDA, The price of the drug molnupiravir also appeared last week. Merck, per dose 700 dollars (an average of 6 thousand 300 TL according to the current exchange rate) determined a fee. It is also stated that 1.7 million doses have already been sold.
Merck isn’t the only company developing an oral antiviral COVID-19 pill. Pfizer Inc. In a statement made in September, he announced that they had started trials for the drug to be used in the treatment of the virus. However, there is no information about the price of this drug yet.